Table 3 Pulse wave analysis in both cohorts
From: Increased augmentation index in patients with Ehlers-Danlos syndrome
|  | EDS cohort (n = 61) | Healthy control cohort (n = 61) | p-value |
|---|---|---|---|
Aortic AIx (AP/PP) @HR 75, % | 22.8 ± 10.1 | 14.8 ± 14.0 | < 0.001 |
P1 height, mmHg | 20 (16/23) | 20 (17/24) | 0.438 |
Peripheral T1, ms | 113 (104/122) | 109 (104/119) | 0.288 |
Peripheral T2, ms | 200 (191/212) | 209 (202/221) | 0.002 |
Peripheral AIx, % | 80.4 ± 18.2 | 72.5 ± 17.2 | 0.017 |
End systolic pressure, mmHg | 102 (92/109) | 97 (91/105) | 0.103 |
Ejection duration, ms | 296 (276/309) | 302 (288/316) | 0.025 |
Heart rate, min−1 | 76 (67/83) | 67 (63/72) | < 0.001 |
Mean pressure systolic, mmHg | 99 (91/107) | 96 (90/102) | 0.142 |
Mean pressure diastolic, mmHg | 89 (82/96) | 85 (79/91) | 0.069 |